In our study, we found enhanced Ser2448 phosphorylation of mTOR in liver tissues from NAFLD mice which could be reduced by anti-TNFR1 treatment. This evidence concerns the gene TNFRSF1A and metabolic dysfunction-associated steatotic liver disease.